Answers are grounded in this paper and cite their sources.
By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at < or =0.12 micro g/ml and 90% of the Mycobacterium chelonae isolates at < or =4 micro g/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.
No takes yet. Share an insight, caveat, or question.
Brown‐Elliott et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: